COBAN PREMIX DIN 02231172
Health Canada record
| Active ingredient(s) | MONENSIN (MONENSIN SODIUM) 200 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 23-Oct-1997 |
| Current status date | 23-Dec-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MONENSIN (MONENSIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02451999 | KEXXTONE | ELANCO CANADA LIMITED | Capsule | MONENSIN (MONENSIN SODIUM) 32.4 G | Marketed |
| 02243232 | MONENSIN PREMIX | BIO AGRI MIX LP | Drug Premix | MONENSIN (MONENSIN SODIUM) 200 G | Marketed |
| 02516772 | MONOVET | HUVEPHARMA EOOD | Drug Premix | MONENSIN (MONENSIN SODIUM) 200 G | Marketed |
| 02231173 | RUMENSIN PREMIX | ELANCO CANADA LIMITED | Drug Premix | MONENSIN (MONENSIN SODIUM) 200 G | Marketed |
| 02082128 | RUMENSIN CRC | ELANCO CANADA LIMITED | Capsule (Extended-Release) | MONENSIN (MONENSIN SODIUM) 32 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21733 | 2019-01-14 | Supplement to a New Drug Submission (SNDS) | NEW SPECIES: SHEEP, GOAT. NEW INDICATION |
| 19959 | 2017-10-25 | New Drug Submission (NDS) | MERGER BUYOUT |
| 17468 | 2015-11-13 | Supplement to a New Drug Submission (SNDS) | LABELLING UPDATE |
| 8069 | 2006-06-22 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL CLAIMS FOR CATTLE |
| 7853 | 2006-03-29 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR THE REMOVAL OF THE LABELLING CAUTION STATEMENT: COBAN PREMIX SHOULD NOT BE FED TO TURKEYS OVER 10 WEEKS OF AGE. |
| 3361 | 2003-11-04 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL SPECIES: CATTLE |
| 6661 | 1997-05-12 | New Drug Submission (NDS) |